Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published July 31, 2006 | Supplemental Material + Published
Journal Article Open

Role of TIF1α as a modulator of embryonic transcription in the mouse zygote

Abstract

The first events of the development of any embryo are under maternal control until the zygotic genome becomes activated. In the mouse embryo, the major wave of transcription activation occurs at the 2-cell stage, but transcription starts already at the zygote (1-cell) stage. Very little is known about the molecules involved in this process. We show that the transcription intermediary factor 1 α (TIF1α) is involved in modulating gene expression during the first wave of transcription activation. At the onset of genome activation, TIF1α translocates from the cytoplasm into the pronuclei to sites of active transcription. These sites are enriched with the chromatin remodelers BRG-1 and SNF2H. When we ablate TIF1α through either RNA interference (RNAi) or microinjection of specific antibodies into zygotes, most of the embryos arrest their development at the 2–4-cell stage transition. The ablation of TIF1α leads to mislocalization of RNA polymerase II and the chromatin remodelers SNF2H and BRG-1. Using a chromatin immunoprecipitation cloning approach, we identify genes that are regulated by TIF1α in the zygote and find that transcription of these genes is misregulated upon TIF1α ablation. We further show that the expression of some of these genes is dependent on SNF2H and that RNAi for SNF2H compromises development, suggesting that TIF1α mediates activation of gene expression in the zygote via SNF2H. These studies indicate that TIF1α is a factor that modulates the expression of a set of genes during the first wave of genome activation in the mouse embryo.

Additional Information

© 2006 Rockefeller University Press. After the Initial Publication Period, RUP will grant to the public the non-exclusive right to copy, distribute, or display the Article under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode, or updates thereof. Submitted: 27 March 2006. Accepted: 7 July 2006. We are grateful to Dr. R. Losson for kindly providing the pSK.TIF1a plasmid, Dr. P. Varga-Weisz for the hSNF2H antibody, Dr. B. Turner for the acetylK14 H3 antibody, and C. Lee for the mouse embryonic fibroblasts. We thank R. Schneider, S. Daujat, P. Varga-Weisz, and K. Ancelin for helpful discussions and A. Bannister, R. Livesely, and J. Pines for critical reading of the manuscript. The initial phase of this work was supported by a Human Frontier Science Program grant awarded to R. Pedersen, J. Rossant, and M. Zernicka-Goetz. This work was supported by the Wellcome Trust. M. Zernicka-Goetz is a Wellcome Trust Senior Research Fellow. M.-E. Torres-Padilla is the recipient of a European Molecular Biology Organization long-term fellowship (ALT 2-2003).

Attached Files

Published - 329.full.pdf

Supplemental Material - 5.pdf

Supplemental Material - JCB200603146_FS1.jpg

Supplemental Material - JCB200603146_FS2.jpg

Supplemental Material - JCB200603146_FS3.jpg

Supplemental Material - JCB200603146_FS4-01.jpg

Files

JCB200603146_FS3.jpg
Files (4.5 MB)
Name Size Download all
md5:cc49322ec9cf0b721ac27d4c13451c64
546.3 kB Preview Download
md5:ae32a038e00eac6b84e38d743312d99e
39.5 kB Preview Download
md5:60e143a5b8ce66433bd488da3db1ffc7
3.1 MB Preview Download
md5:c9f781c71e16e5b68dd69096eb87f26d
282.4 kB Preview Download
md5:429652f7f54c931ae13b178449e3ec59
30.8 kB Preview Download
md5:7af0b29ff4a84ad3dfc9f1ae45ef0e1f
569.3 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 20, 2023